Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: cyclophosphamide|DRUG: Docetaxel|DRUG: epirubicin hydrochloride|DRUG: fluorouracil|DRUG: ixabepilone
Sponsor: UNICANCER